Tumor and immune determinants of response to anti-BCMA CAR T-cell therapy in multiple myeloma using cell-free DNA

被引：0
|
作者：
Carleton, Mia
Hosoya, Hitomi
Tanaka, Kailee L.
Sworder, Brian
Hovanky, Vanna
Sahaf, Bita
Frank, Matthew J.
Duran, George E.
Zhang, Tian Y.
Arai, Sally
Iberri, David
Liedtke, Michaela
Miklos, David B.
Khodadoust, Michael S.
Sidana, Surbhi
Kurtz, David M.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5707
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5707
引用
收藏
页数：3
相关论文
共 50 条
  • [41] An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously
    Wang, Qingming
    Wei, Runhong
    Guo, Shufang
    Min, Chao
    Zhong, Xiong
    Huang, Hui
    Cheng, Zhi
    CANCER GENE THERAPY, 2024, 31 (01) : 108 - 118
  • [42] Hematopoietic reconstitution and infections after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma are associated with pre-CAR-T bridging therapies
    Frenking, Jan
    Kauer, Joseph
    Hajiyianni, Marina
    Mai, Elias
    Michel, Christian
    Sester, Lilli
    John, Lukas
    Mueller-Tidow, Carsten
    Goldschmidt, Hartmut
    Weinhold, Niels
    Schmitt, Anita
    Schmitt, Michael
    Dreger, Peter
    Sauer, Sandra
    Raab, Marc
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S38 - S39
  • [43] An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously
    Qingming Wang
    Runhong Wei
    Shufang Guo
    Chao Min
    Xiong Zhong
    Hui Huang
    Zhi Cheng
    Cancer Gene Therapy, 2024, 31 : 420 - 426
  • [44] A Phase Ib/II Study of Trovocabtagene Autoleucel (C-CAR088), an Anti-BCMA CAR T-Cell Therapy in Relapsed or Refractory Multiple Myeloma
    An, Gang
    Xu, Yan
    Yi, Shuhua
    Lyu, Rui
    Huang, Jiaqi
    Li, Wensi
    Zhang, Yiran
    Lan, Liping
    Qiu, Lugui
    BLOOD, 2024, 144 : 7235 - 7236
  • [45] Anti-BCMA CAR T-Cell Therapy in a Patient with Refractory Anti-SRP Necrotizing Myopathy
    Qin, Chuan
    Dong, Ming-Hao
    Zhou, Luo-Qi
    Wang, Wen
    Song-Bai
    Li, Chun-Rui
    Wang, Di
    Zhang, Min
    Bu, Bi-Tao
    Tian, Dai-Shi
    Wang, Wei
    ANNALS OF NEUROLOGY, 2024, 96 : S99 - S100
  • [46] Efficacy of Humanized Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With and Without Extramedullary Disease
    Deng, Haobin
    Liu, Meijing
    Yuan, Ting
    Zhang, Huan
    Cui, Rui
    Li, Jingyi
    Yuan, Jijun
    Wang, Xiaofang
    Wang, Yafei
    Deng, Qi
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [47] Nivolumab-Based Salvage Therapy to Restore T Cell Fitness in Penta-Refractory Multiple Myeloma with Relapse to Anti-BCMA CAR T Cell Therapy
    Waldschmidt, Johannes M.
    Arora, Sankalp
    Vijaykumar, Tushara
    Sotudeh, Noori
    Anand, Praveen
    Stuart, Hannah
    Frede, Julia
    Campbell, Tim
    Kaiser, Shari M.
    Lamba, Manisha
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    Yee, Andrew J.
    Knoechel, Birgit
    Lohr, Jens G.
    Raje, Noopur
    BLOOD, 2022, 140 : 9925 - 9926
  • [48] sBCMA Plasma Level Dynamics and Anti-BCMA CAR-T-Cell Treatment in Relapsed Multiple Myeloma
    Seipel, Katja
    Porret, Naomi
    Wiedemann, Gertrud
    Jeker, Barbara
    Bacher, Vera Ulrike
    Pabst, Thomas
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2022, 44 (04) : 1463 - 1471
  • [49] Real world single center expeirence of long-term toxicities with anti-BCMA CAR T-cell therapy in relapsed and refractory multiple myeloma
    Costello, Patrick
    Laubach, Jacob
    Mo, Clifton
    Sperling, Adam
    Nikiforow, Sarah
    Redd, Robert
    Ramsdell, Linda
    Finn, Kathleen
    Desnoyers, Lauren
    Denisco, Michelle
    Fraser, Esther
    Bianchi, Giada
    Hartley-Brown, Monique
    Ghobrial, Irene
    Richardson, Paul
    Anderson, Kenneth
    Munshi, Nikhil
    Nadeem, Omar
    Midha, Shonali
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S54 - S54
  • [50] Combination Anti-Bcma and Anti-CD19 CAR T Cells As Consolidation of Response to Prior Therapy in Multiple Myeloma
    Garfall, Alfred L.
    Cohen, Adam D.
    Lacey, Simon F.
    Tian, Lifeng
    Hwang, Wei-Ting
    Vogl, Dan T.
    Waxman, Adam
    Lancaster, Eric
    Nelson, Anne Marie
    Ferthio, Regina
    Fesnak, Andrew
    Lamontagne, Anne
    Brennan, Andrea
    Guilliams, Jamie
    Gladney, Whitney Lynn
    Melenhorst, J. Joseph
    Young, Regina M.
    Siegel, Don L.
    Levine, Bruce L.
    Brogdon, Jennifer
    Isaacs, Randi E.
    June, Carl H.
    Milone, Michael C.
    Stadtmauer, Edward A.
    BLOOD, 2019, 134
12345